Last reviewed · How we verify
Candida Peritonitis
Approved treatments
- Cancidas · Merck & Co.
Cancidas works by inhibiting the synthesis of beta-1,6-glucan, a critical component of the fungal cell wall. - Eraxis · Vicuron Holdings
Eraxis works by inhibiting the synthesis of beta-1,3-D-glucan, a critical component of the fungal cell wall. - Mycamine · Teva Pharms Usa Inc
- Abelcet · Astellas Pharma
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Candida Peritonitis patent landscape — cliff calendar, originator estates, attackable patents
- Candida Peritonitis treatment landscape brief
- Candida Peritonitis treatment updates RSS
Frequently asked questions about Candida Peritonitis
What drugs treat Candida Peritonitis?
Tracked treatments include Cancidas, Eraxis, Mycamine, Abelcet.
What is the treatment for Candida Peritonitis?
Standard treatment for Candida Peritonitis includes Cancidas, Eraxis, Mycamine, Abelcet. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Candida Peritonitis patent cliff · Candida Peritonitis CI report
- Treatment: Cancidas · Merck & Co.
- Treatment: Eraxis · Vicuron Holdings
- Treatment: Mycamine · Teva Pharms Usa Inc
- Treatment: Abelcet · Astellas Pharma
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing